Search - tctmd.com

August 30, 2019

News Daily News

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

August 22, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

August 16, 2019

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

News Daily News

FDA: Class I Recall for Ellipse ICD Due to Faulty Wires

August 05, 2019

News Daily News

New Recall for Maquet/Datascope IABPs Due to Potential Battery Failure

Marcus A. Banks

July 24, 2019

News Daily News

Burst Balloons With Sapien 3 Ultra Prompt ‘Urgent Field Safety Notice’ and Canadian Recall

July 22, 2019

News Daily News

FDA: Class I Recall for IntraClude Intra-Aortic Occlusion Device

July 02, 2019

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Daily News

Terumo’s Solopath Transfemoral System and Recollapsible Balloon Access System Recalled for Dislodging Issues

May 30, 2019

News Daily News

FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting

Todd Neale

May 21, 2019

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

May 08, 2019

News Daily News

FDA Warns of Premature Battery Depletion With Certain Medtronic Pacemakers

May 07, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

May 01, 2019

News Daily News

Two Pediatric Cardiac Catheters Recalled for Defective Balloons

April 26, 2019

News Daily News

FDA Warns Against Off-label Use of Wingspan Stent System

Todd Neale

April 25, 2019

News Daily News

FDA Warns of Cybersecurity Vulnerabilities With Some Medtronic Implanted Devices

March 22, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

March 21, 2019

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD